TAK-580 is a 1,3-thiazolecarboxamide, specifically 2-[(1R)-1-aminoethyl]-1,3-thiazole-5-carboxylic acid, formed by the formal condensation of the carboxy group with the amino group of 5-chloro-4-(trifluoromethyl)pyridin-2-amine and the amino group with the carboxy group of 6-amino-5-chloropyrimidine-4-carboxylic acid. It is a pan-RAF kinase inhibitor in clinical development for radiographically recurrent or progressive low-grade glioma in children and young adults. It functions as an antineoplastic agent, apoptosis inducer, and B-Raf inhibitor. It is classified as a chloropyridine, organofluorine compound, secondary carboxamide, aminopyrimidine, pyrimidinecarboxamide, and 1,3-thiazolecarboxamide.
